Achromatopsia (ACHM) Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Long-Term Follow-Up Gene Therapy Study for Achromatopsia CNGB3
Condition: Achromatopsia Intervention: Biological: AAV - CNGB3 Sponsors: MeiraGTx UK II Ltd; Syne Qua Non Limited; Emas Pharma Ltd. Recruiting - verified September 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 16, 2017 Category: Research Source Type: clinical trials